Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Inv. presentation
|
|
Eloxx Pharmaceuticals, Inc. (ELOX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Rubin Steven D (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 2,859 options to buy
@ $4, valued at
$11.4k
|
|
| 01/31/2023 |
4
| Kariv Tomer (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 2,859 options to buy
@ $4, valued at
$11.4k
|
|
| 01/31/2023 |
4
| Androski Lindsay (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 2,859 options to buy
@ $4, valued at
$11.4k
|
|
| 01/27/2023 |
4
| Aggarwal Sumit (PRESIDENT AND CEO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 68,700 options to buy
@ $4.27, valued at
$293.3k
|
|
| 01/27/2023 |
4
| MODUR VIJAY (HEAD OF R&D) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.27, valued at
$128.1k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Walts Alan Edmund (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.26, valued at
$5.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Seehra Jasbir (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.26, valued at
$5.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| PAREKH RAJESH B (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.26, valued at
$5.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Kariv Tomer (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.26, valued at
$5.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Walts Alan Edmund (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Exercised 37,695 restricted stock units
@ $0 |
|
| 12/03/2021 |
4
| Aggarwal Sumit (PRESIDENT AND CEO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 81,933 shares
@ $0.72, valued at
$59k
Exercised 279,158 restricted stock units
@ $0 |
|
| 12/03/2021 |
4
| MODUR VIJAY (HEAD OF R&D) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 64,373 shares
@ $0.72, valued at
$46.3k
Exercised 219,326 restricted stock units
@ $0 |
|
| 12/01/2021 |
4
| Geffken Daniel E. (INTERIM CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 50,000 shares
@ $0.72, valued at
$36k
|
|
| 07/30/2021 |
4
| Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 459 shares
@ $1.32, valued at
$605.9
Exercised 1,563 restricted stock units
@ $0 |
|
| 05/26/2021 |
4
| Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,835 shares
@ $1.39, valued at
$2.6k
Exercised 6,250 restricted stock units
@ $0 |
|
| 05/20/2021 |
4
| Walts Alan Edmund (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 3,334 options to buy
@ $1.48, valued at
$4.9k
|
|
| 05/20/2021 |
4
| PAREKH RAJESH B (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 3,334 options to buy
@ $1.48, valued at
$4.9k
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.48, valued at
$29.6k
|
|
| 05/20/2021 |
4
| Kariv Tomer (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.48, valued at
$29.6k
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Rubin Steven D (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.48, valued at
$29.6k
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| MODUR VIJAY (HEAD OF R&D) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 496,204 options to buy
@ $1.41, valued at
$699.6k
|
|
| 05/18/2021 |
4
| Aggarwal Sumit (PRESIDENT AND CEO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 992,409 options to buy
@ $1.41, valued at
$1.4M
|
|
| 05/17/2021 |
4
| PAREKH RAJESH B (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 84,776 shares
@ $1.35, valued at
$114.4k
Bought 2,381,890 shares
@ $1.35, valued at
$3.2M
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 1,280,624 shares
@ $1.35, valued at
$1.7M
Bought 2,630,487 shares
@ $1.35, valued at
$3.6M
Bought 1,422,222 shares
@ $1.35, valued at
$1.9M
Bought 592,592 shares
@ $1.35, valued at
$800k
|
|
|
|
|